Quidel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-05-2024
- Paid Up Capital ₹ 0.10 M
as on 18-05-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2017)
- Profit 62.92%
(FY 2017)
- Ebitda
- Net Worth -12.34%
(FY 2017)
- Total Assets -11.36%
(FY 2017)
About Quidel Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sima Devi and Kumari Mishra serve as directors at the Company.
- CIN/LLPIN
U24100WB2015PTC206333
- Company No.
206333
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quidel Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sima Devi  | Director | 16-Mar-2020 | Current |
| Kumari Mishra | Director | 13-May-2015 | Current |
Financial Performance of Quidel Pharmaceuticals.
Quidel Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Quidel Pharmaceuticals?
In 2017, Quidel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quidel Pharmaceuticals?
Unlock and access historical data on people associated with Quidel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quidel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quidel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
